DIFFERENTIAL METHYLATION AS A BIOMARKER OF RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Plant, D. [1 ]
Webster, A. [2 ]
Nair, N. [2 ]
Oliver, J. [2 ]
Smith, S. [2 ]
Eyre, S. [2 ]
Hyrich, K. L. [2 ]
Wilson, A. G. [3 ]
Morgan, A. W. [4 ,5 ]
Isaacs, J. [6 ,7 ]
Worthington, J. [1 ,2 ]
Barton, A. [1 ,2 ]
机构：
[1] Manchester Acad Hlth Sci, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
[3] Univ Coll Dublin, UCD Sch Med & Med Sci, Conway Inst, Dublin, Ireland
[4] Univ Leeds, Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[6] Newcastle Univ, NIHR Newcastle Biomed Res Ctr Ageing & Chron Dis, Newcastle Upon Tyne, Tyne & Wear, England
[7] Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-209124.156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A8.03
引用
收藏
页码：A66 / A66
页数：1
相关论文
共 50 条
  • [11] DIFFERENTIAL METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nair, Nisha
    Plant, Darren
    Isaacs, John
    Morgan, Ann
    Hyrich, Kimme
    Barton, Anne
    Wilson, Gerry
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 669 - 669
  • [12] DIFFERENTIAL DNA METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS
    Nair, N.
    Plant, D.
    Isaacs, J.
    Morgan, A.
    Hyrich, K.
    Barton, A.
    Wilsonon, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 220 - 220
  • [13] Switching to etanercept in patients with rheumatoid arthritis with no response to infliximab.
    Di Poi, Emma
    Perin, Antonella
    Morassi, Maria Pia
    Del Frate, Marino
    Ferraccioli, Gianfranco
    De Vita, Salvatore
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : 85 - 87
  • [14] Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis
    Iagnocco, A.
    Perella, C.
    Ceccarelli, F.
    Tripodo, E.
    Alessandri, C.
    Magrini, L.
    Valesini, G.
    REUMATISMO, 2006, 58 (03) : 233 - 238
  • [15] Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
    Gómez-Puerta, JA
    Sanmartí, R
    Rodríguez-Cros, JR
    Cañete, JD
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 896 - 896
  • [16] Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab
    Sanmartí, R
    Gómez-Puerta, JA
    Rodríguez-Cros, JR
    Albaladejo, C
    Muñoz-Gómez, J
    Cañete, JD
    MEDICINA CLINICA, 2004, 122 (09): : 321 - 324
  • [17] CORRELATION BETWEEN THE SERUM ETANERCEPT LEVEL AND RESPONSE TO ETANERCEPT TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zivojinovic, S. M.
    Sefik-Bukilica, M.
    Damjanov, N. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 559 - 560
  • [18] Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis
    Nair, Nisha
    Plant, Darren
    Verstappen, Suzanne M. M.
    Isaacs, John D.
    Morgan, Ann W.
    Hyrich, Kimme L.
    Barton, Anne
    Wilson, Anthony G.
    RHEUMATOLOGY, 2020, 59 (06) : 1364 - 1371
  • [19] Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
    Wakabayashi, Hiroki
    Sudo, Akihiro
    Nishioka, Yosuke
    Hasegawa, Masahiro
    Minami, Yukari
    Nishioka, Kusuki
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (11) : 3675 - 3678
  • [20] Predictors of response to etanercept and infliximab among patients with rheumatoid arthritis (RA)
    Hyrich, KL
    Watson, KD
    Symmons, DPM
    Silman, AJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 429 - 429
12345